Your cart is empty
The first comprehensive and most recent overview of the topic, this
ready reference and handbook reviews current knowledge of TAAs,
their subclasses, and pinpoints their application areas in
medicine. In addition, it emphasizes target identification
procedures, the need for an accurate and thorough analysis of the
function of TAAs, and the validation of those in clinical settings.
The whole is rounded off with an overview of currently approved
This volume reviews disparities in cancer genetics, etiology, treatment and survivorship that are associated with differences in energy balance and how those differences and disparities may be affected by geography, socioeconomic status, ethnicity, biology, behavior and others. State-of-the-art strategies are outlined to alter these problems at the individual, community and policy levels. The book provides a comprehensive assessment of the multiple contributions of disparities in energy balance and how they affect cancer. this volume should constitute a valuable resource to disparity focused investigators at all levels and serves an important guide to professionals that deal with these issues, especially those who determine and implement policy."
Understanding Liver Cancer is a concise and up-to-date review, which discusses diagnosis, management, patient care, current and emerging therapies, and useful resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of liver cancer as well as a summary of current therapies will benefit from this succinct text."
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15-25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes. However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer provides oncologists, primary care physicians, trainees and other healthcare providers with a concise, accessible, and up-to-date survey of the field, including a review of our current understanding of the biology of the HER2 pathway and the rationale for targeting it in early-stage and advanced breast cancer, an overview of HER2-testing, and evidence-based discussions of available HER2-targeted regimens in the adjuvant and metastatic settings.
This book provides hands-on information on how to manage pregnant cancer patients in clinical practice. In this context a multidisciplinary perspective is essential, and contributions are accordingly presented from experts in surgical management, medical oncology, radiotherapy, pharmacokinetics, obstetric care, psychological care, neonatal and pediatric care. In addition a series of chapters focused on management in particular disease settings are presented, including breast cancer, melanoma, cervical cancer, ovarian tumors, lymphoma, leukemia, and thoracic cancers. The book reflects the major progress that has been achieved in the care of pregnant cancer patients in the recent years as important data have become available on patient management, and fetal safety in addition to valuable preclinical research on the impact of pregnancy on pharmacokinetics of anti-cancer agents. Edited and authored by worldwide leaders in the field, it will serve as a valuable resource not only for oncologists but also for obstetricians, gynecologists, neonatologists, and pediatricians caring for pregnant cancer patients and their newborns.
A Quick Guide to Cancer Epidemiology is an ideal addition to Springer Briefs in Cancer Research. The Brief provides core concepts in cancer epidemiology and also gives a snapshot of the epidemiology of seventeen human cancers. The Brief aims to provide-with quantitative focus-estimates of the global burden of neoplasms, of recent and likely future trends, distribution, causes and strategies for prevention for major groups of cancers. Finally, the Brief will give an overview of severals factors that cause cancer including dietary factors, tobacco smoking, obesity and alcohol consumption.
Pocketbook for Cancer Supportive Care Febrile Neutropenia is a comprehensive review on febrile neutropenia, its prevention, risks, management, costs, and special populations affected by the condition. The book was originally commissioned due to advances in the field, and to supplement the series: Pocketbooks in Supportive Cancer Care. Busy healthcare professionals who have a basic understanding of febrile neutropenia but want to learn more a will benefit from this concise guide that will help them quickly understand the complexities of this condition.
Leading researchers are specially invited to provide a complete understanding of a key topic within the multidisciplinary fields of physiology, biochemistry and pharmacology. In a form immediately useful to scientists, this periodical aims to filter, highlight and review the latest developments in these rapidly advancing fields.
Photodynamic Therapy: From Theory to Application brings attention to an exceptional treatment strategy, which until now has not achieved the recognition and breadth of applications it deserves. The authors, all experts and pioneers in their field, discuss the history and basic principles of PDT, as well as the fundamentals of the theory, methods, and instrumentation of clinical diagnosis and treatment of cancer. Non-oncological applications such as the use of PDT in control of parasites and noxious insects are also discussed. This book serves as a standard reference for researchers and students at all levels, clinical specialists interested in the topic and those in industry exploring new areas for development. A comprehensive exposition of both the theory and application of PDT, this book fills the gaps in the current literature by bringing together both basic understanding of the process of PDT and an expanded vision of its applications.
ABC of Cancer Care is a practical primary care guide to help health professionals better inform their patients, manage and recognize the common complications of cancers and their treatment, and understand the rationale and implications of decisions made in secondary and tertiary care. It provides coverage of the diagnosis, management, treatment and on-going surveillance of common cancers within the multidisciplinary context of primary care. Individual chapters assess the different treatment options, including surgery, radiotherapy and chemotherapy, and examine their possible side effects. The contribution of clinical trials and new advances in cancer treatment including biological and targeted therapies, robotic surgery and advanced radiotherapy techniques are all described. Other aspects of cancer care, from nursing support and nutrition to psychological care and survivorship, are also covered. Edited by a specialist and general practitioner team, with multidisciplinary contributors, ABC of Cancer Care is ideal for general practitioners, practice nurses, cancer care nurses, medical students, and all healthcare professionals treating and supporting cancer patients. This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from iTunes, Google Play or the MedHand Store.
`This book creates new ground for all health professionals working in cancer care to read, enjoy, look at and question their practice.' Caroline Adcock, Clinical Practice Educator - Haematology and Oncology, Royal Shrewsbury Hospital Cancer and Cancer Care is a complete study of cancer, the care of people with the disease and its impact on everyday life. Addressing the physical and psychosocial aspects of the illness in detail, it covers all fundamental aspects of cancer diagnosis, treatment, survival and aspects of psychosocial support for all those affected by cancer: patients, their families, and their healthcare providers. Chapters include: - A review of the latest theory and evidence on over 30 separate topic areas - Reflective questions which challenge readers to reappraise what they have learned - Chapter overviews and chapter summaries which highlight the key points The book is essential reading for all those on cancer care courses at undergraduate and postgraduate level. It will be valuable reading for nurses, oncologists, psychologists, social workers and all healthcare practitioners and researchers working with people affected by cancer.
How to identify optimal phase II trial designs Providing a practical guide containing the information needed to make crucial decisions regarding phase II trial designs, A Practical Guide to Designing Phase II Trials in Oncology sets forth specific points for consideration between the statistician and clinician when designing a phase II trial, including issues such as how the treatment works, choice of outcome measure and randomization, and considering both academic and industry perspectives. A comprehensive and systematic library of available phase II trial designs is included, saving time otherwise spent considering multiple manuscripts, and real-life practical examples of using this approach to design phase II trials in cancer are given. A Practical Guide to Designing Phase II Trials in Oncology: * Offers a structured and practical approach to phase II trial design. * Considers trial design from both an academic and industry perspective. * Includes a structured library of available phase II trial designs. * Is relevant to both clinical and statistical researchers at all levels * Includes real life examples of applying this approach. * For those new to trial design, A Practical Guide to Designing Phase II Trials in Oncology will be a unique and practical learning tool, providing an introduction to the concepts behind informed decision making in phase II trials. For more experienced practitioners, the book will offer an overview of new, less familiar approaches to phase II trial design, providing alternative options to those which they may have previously used.
Volume 13: Pineal, Pituitary, and Spinal Tumors is organized in six sections, for convenience and quick access to critical information. Section I, Types of Tumors includes a chapter on molecular characterization of Embryonal tumors, a chapter on diagnosis of metastatic oligodendroglioma using fine-needle aspiration cytology, one covering intra-arterial chemotherapy of oligodendroglial tumors and another on the role of cyclooxygenase-2 in the development and growth of Schwannomas, and others, closing with a chapter on trigeminal neuralgia with cerebellopontine angle tumors. Section II, Diagnosis, includes two chapters on cell counting in histopathologic slides of tumors. Section III offers three chapters which discuss aspects of intraoperative ultrasonography. Section IV covers brain tumor surgery, and Section V surveys Brain Metastasis. The final section offers a wide-ranging review of General Diseases, with chapters on, among others, Alexander Disease; Lipoma; Transplantation of human umbilical cord blood mononuclear cells in cases of neonatal hypoxic-ischemic brain damage; and a chapter discussing the use of mobile phones and brain cancer risk in children. Like its twelve predecessors in the series, this volume merits distinction for its thorough approach, its roster of 78 distinguished contributors representing 14 different countries and its detailed examination of leading-edge technology and methods.
Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of cancer diagnosis and treatment taking a balanced, authoritative and, -where possible- evidence-based stance. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a comprehensive understanding of the field of oncology, with an emphasis on prevention and early detection.
This book is designed as a reference and working guide for practitioners who deal with patients with neoplastic diseases of the urinary tract and male genitalia, including tumors of the kidney, ureter and urinary bladder, prostate, testis, adrenal gland, and retroperitoneum. Each chapter describes and illustrates key imaging findings relevant to the characterization, differential diagnosis, and staging of lesions. Pattern recognition is facilitated through the use of schematic drawings, and imaging findings on post-treatment follow-up also form an important component of the book. Brief core descriptions of related multidisciplinary fields, such as nuclear medicine, pathology, urologic surgery, and radiation oncology are included whenever relevant.
This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib.
This pocket book provides up-to-date descriptions of the most relevant features of neuroendocrine tumors (NETs) and the imaging modalities currently available to assist specialists (clinicians, pathologists, radiologists, nuclear medicine physicians) in selecting optimal patient management based on interdisciplinary collaboration. As the title indicates, the focus is particularly on PET/CT, with coverage of basic principles, the available radiopharmaceuticals, indications, typical and atypical appearances, normal variants and artifacts, advantages, limitations, and pitfalls. In addition, succinct information is provided on the use of other imaging modalities, including SPECT, CT, and MRI, and on pathology and treatment options. Imaging teaching cases are presented, and key points are highlighted throughout. The book is published as part of a series on hybrid imaging that is specifically aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings.
This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.
The "TNM Supplement," 4th Edition, includes new, detailed definitions of anatomical sites, regional lymph nodes, and TNM categories. It answers questions that frequently arise during daily use of the TNM system. Importantly, the "TNM Supplement" expands on the minimum requirements for pathological classification of individal tumour sites and enumerates the recommended criteria for each. Published in association with the Union for International Cancer Control, it provides oncologists with complementary material related to TNM staging not covered in "TNM Classification of Malignant Tumours, 7th Edition."
Rare Genitourinary Tumors offers the reader an up-to-date discussion of the less common neoplasms affecting the urinary tract and reproductive organs. Each authoritative chapter provides and in-depth discussion that is frequently not found in other urologic oncology textbooks. A valuable reference for urologists, oncologists, and those in specialty training, this volume provides ready access to information on etiology, incidence, risk factors, diagnosis, prognosis, insights from molecular pathology and, where applicable, data from clinical trials. The practical treatment guidelines included for each tumor type are written by experts and fully referenced.
This comprehensive atlas is unique in being devoted to the MRI appearances of bone marrow in the axial and appendicular skeleton of adults and children. Normal MRI findings, including common variants and degenerative changes, are first documented. MRI appearances in the entire spectrum of neoplastic and non-neoplastic infiltrative marrow disorders are then presented, with accompanying explanatory text. Among the conditions considered are multiple myeloma, the acute and chronic leukemias, diffuse metastases, diffuse lymphomas, the anemias, polycythemia vera, myelofibrosis, storage disorders, and infections. Characteristic changes to bone marrow following various forms of treatment are also displayed and discussed. The selected images reflect the use of a variety of sequences and techniques, such as fat suppression, chemical shift imaging, and contrast-enhanced imaging.
There has been a change in the management of patients with localized cancer from total mastectomy to lumpectomy complemented by adjuvant radiotherapy and chemo-endocrine therapy, without significant outcome. Early detection of small breast carcinoma lesions may further change the attitude toward less invasive and even noninvasive management. A major goal of breast-conserving treatment is the preservation of a cosmetically acceptable breast. Although a variety of patient and treatment factors have been reported to influence the cosmetic result, the amount of resected breast tissue appears to be the major factor. Several investigators are currently studying the feasibility of percutaneous minimally invasive techniques to ablate breast tumors. And several modalities such as cryosurgery, laser ablation, thermoablation, and high-intensity focused ultrasound have been investigated.Radiofrequency ablation (RFA) has been demonstrated to be effective for treating tumors in many types of tissue, including liver, bone, brain, kidney, pancreas and prostate tissue.By minimizing damage and disruption to normal surrounding tissue, the morbidity of local treatment such as scarring and deformity can be reduced, and cosmetic results can be potentially improved. With the widespread application of screening mammography, the mean size of the breast tumors which can be detected has continued to decrease, which further emphasize the need for less invasive methods that can deliver local tumor destruction such as RF ablation.This new frontier of surgery without scalpels will require surgeons to improve their radiological expertise and basic understanding of molecular biology.Our phase I / II study was conducted to determine the safety and efficacy of radiofrequency ablation of early breast carcinomas using saline-cooled electrodes. RFA could represent an alternative local treatment to replace breast-conserving surgery for early breast cancer.
This book offers a comprehensive guide to state-of-the-art techniques in functional urologic surgery that minimize functional damage to the urinary tract and are of particular value in patients with oncologic or neurogenic diseases. It describes the main minimally invasive surgical techniques currently available step by step, while also offering guidance on indications and how to select appropriate surgical devices to achieve specific oncological and functional outcomes. Further, the book presents data from relevant case series, documenting the favorable functional and oncologic results achieved with these techniques and devices as well as the low associated morbidity and positive impacts on quality of life. Lastly, it offers advice on preoperative assessment and postoperative care, and presents specific diagnostic algorithms of value in daily clinical practice. The contributing authors represent an international mix of respected experts carefully selected for their knowledge of the topics discussed.
This invaluable manual provides a practical overview of the field of gynecologic oncology. Focusing on clinical aspects of the specialty, it provides hands-on guidance for those caring for patients with ovarian, cervical, uterine, and lower genital tract cancers. It describes the current epidemiology, pathophysiology, presentation, diagnosis, and multimodality management of the most common gynecologic malignancies. Chapters are also devoted to radiation and chemotherapy, as well as symptom management. The book is designed for quick reference.
You may like...
Prostrate Cancer - The Essential Guide
Robert Duffy Paperback
So You Want to Build a Startup?
Matthew Buckland Paperback
Plants that Fight Cancer
Spiridon E. Kintzios, Maria G. Barberaki Hardcover R3,695 Discovery Miles 36 950
Mum's Not Having Chemo - Cutting-edge…
Laura Bond Paperback
Cancer: A Love Story - Memoir Of A…
Lauren Segal Paperback (1)
Pretty Sick - The Beauty Guide for Women…
Caitlin Kiernan Paperback (1)
For Freddie - A Mother's Final Gift to…
Rachael Bland Hardcover (1)
After Cleo, Came Jonah
Helen Brown Paperback (1)
F*** You Cancer - How to face the big C…
Deborah James Paperback (1)
The Twinkling of an Eye - A mother's…
Sue Brown Paperback